Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Intermediate-Size Population Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Patients with Multiple Myeloma

Multiple Myeloma

Disease Sites: Multiple Myeloma

Phase: N/A

Investigator: Oluwole, Olalekan

NCTID: NCT05346835

Protocol No: VICC-XDCTT24033

A First-In-Human, Phase 1, Dose-Escalation Study of SGR-3515 In Participants with Advanced Solid Tumors

Disease Sites: Not Available

Phase: I

Investigator: Gibson, Mike

NCTID: NCT06463340

Protocol No: VICC-DTPHI24100

A Phase 1, Open-Label, Multicenter Study of INCB160058 in Participants With Myeloproliferative Neoplasms

Disease Sites: Not Available

Phase: I

Investigator: Kishtagari, Ashwin

NCTID: NCT06313593

Protocol No: VICC-DTHEM24055P

Phase Ib Study of Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia

Disease Sites: Not Available

Phase: I

Investigator: Ball, Somedeb

NCTID: NCT06399640

Protocol No: VICC-VCHEM23008P

Clinical Trial Flowcharts
for Referring Physicians

Clinical Trial Flowcharts
for VICC Staff (VUNetID required)

Clinical Trials Search CTA Inline Referral Form